Have a personal or library account? Click to login
A case report: cold hemagglutinin disease in a pancreatic and renal transplant patient Cover

A case report: cold hemagglutinin disease in a pancreatic and renal transplant patient

By: C.Y Beiting and  K.S. Larimore  
Paid access
|Dec 2020

Abstract

A 33-year-old white male, 30 days postpancreatic transplant, with a history of juvenile onset diabetes mellitus and previous renal transplant, appeared to have cold hemagglutinin disease (CHD). He was being treated for acute organ rejection and had received two units of red blood cells (RBCs) on postoperative day 11, at which time no serum antibodies were detectable. On postoperative day 30, serum studies showed an autoanti-I with a titer of 512 in 30 percent albumin at 4°C and a maximum thermal amplitude of 37°C. The patient had a weakly positive direct antiglobulin test (DAT) with only complement detectable on the red cells. The patient recovered spontaneously. The etiology of the CHD is unclear. The use of cyclosporin-A, OKT3 monoclonal anti-body, and anti-thymocyte globulin (ATG) to treat acute rejection could have played a part.

DOI: https://doi.org/10.21307/immunohematology-2019-1112 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 71 - 74
Published on: Dec 29, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 C.Y Beiting, K.S. Larimore, published by American National Red Cross
This work is licensed under the Creative Commons License.